Showing results (11-20 of 88) with videos related to

Sort By:
Pageof 9
Cancers|October 16, 2024
Unravelling the Complexity of HNSCC Using Single-Cell TranscriptomicsCristina Conde-Lopez, Divyasree Marripati, Moshe Elkabets, et al.
Trends in Cancer|June 19, 2019
Adaptive Responses to Monotherapy in Head and Neck Cancer: Interventions for Rationale-Based Therapeutic CombinationsSankar Jagadeeshan, Manu Prasad, Sandra Ortiz-Cuaran, et al.
Scientific Reports|July 24, 2023
Developing a dual VEGF/PDL1 inhibitor based on high-affinity scFv heterodimers as an anti-cancer therapeutic strategyNoam Tzuri, Ksenia M Yegodayev, Ofra Novoplansky, et al.
International Journal of Molecular Sciences|July 9, 2022
The Contribution of the Minimal Promoter Element to the Activity of Synthetic Promoters Mediating CAR Expression in the Tumor MicroenvironmentYariv Greenshpan, Omri Sharabi, Ksenia M Yegodayev, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 9, 2011
Microenvironment-derived IL-1 and IL-17 interact in the control of lung metastasisYaron Carmi, Gal Rinott, Shahar Dotan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 20, 2010
Sialylation of 3-methylcholanthrene-induced fibrosarcoma determines antitumor immune responses during immunoeditingMerav Cohen, Moshe Elkabets, Michal Perlmutter, et al.
Nanomaterials (Basel, Switzerland)|July 14, 2023
Cargo-Dependent Targeted Cellular Uptake Using Quaternized Starch as a CarrierYossi Blitsman, Chen Benafsha, Nir Yarza, et al.
Molecular & Cellular Oncology|June 17, 2016
Rationale-based therapeutic combinations with PI3K inhibitors in cancer treatmentPau Castel, Eneda Toska, Zachary S Zumsteg, et al.
Scientific Reports|May 27, 2018
Enhanced ZnR/GPR39 Activity in Breast Cancer, an Alternative Trigger of Signaling Leading to Cell GrowthHila Ventura-Bixenshpaner, Hila Asraf, Moumita Chakraborty, et al.
Pageof 9